C12Y 114/11002
Procollagen-proline dioxygenase , i.e. proline-hydroxylase
Official title: Procollagen-proline dioxygenase (1.14.11.2), i.e. proline-hydroxylase
C12Y114/11002 (Procollagen-proline dioxygenase , i.e. proline-hydroxylase) appears on 56 US grants and 86 published applications in this corpus.
Search patents in C12Y- Granted patents
- 56
- Published applications
- 86
- Assignees
- 54
- Inventors
- 169
- Latest grant
- 1 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 2 | 4 |
| 2003 | 1 | 1 |
| 2004 | 1 | 3 |
| 2005 | 1 | 1 |
| 2006 | 1 | 0 |
| 2007 | 1 | 1 |
| 2008 | 0 | 0 |
| 2009 | 0 | 6 |
| 2010 | 1 | 3 |
| 2011 | 2 | 3 |
| 2012 | 0 | 5 |
| 2013 | 3 | 5 |
| 2014 | 5 | 2 |
| 2015 | 1 | 5 |
| 2016 | 1 | 3 |
| 2017 | 6 | 5 |
| 2018 | 0 | 5 |
| 2019 | 7 | 6 |
| 2020 | 3 | 3 |
| 2021 | 5 | 4 |
| 2022 | 2 | 3 |
| 2023 | 3 | 5 |
| 2024 | 0 | 4 |
| 2025 | 4 | 7 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Biocatalysts and methods for hydroxylation of chemical compounds1 Jul 2025US 12,344,865 B2Codexis, Inc.
- Fusion proteins for hydroxylating amino acids and products13 May 2025US 12,296,037 B2Htl Biotechnology Innovation, Inc.
- Engineered proline hydroxylase biocatalysts for hydroxylation of chemical compounds29 Apr 2025US 12,286,648 B2Codexis, Inc.
- Biocatalysts and methods for hydroxylation of chemical compounds11 Mar 2025US 12,247,234 B2Codexis, Inc.
- Proline hydroxylase and uses thereof28 Nov 2023US 11,827,909 B2Asymchem Laboratories (Fuxin) Co., Ltd.
- Expression of modified proteins in a peroxisome13 Aug 2026US 2026/0234647 A1The Regents of the University of California
- Systems and methods for producing collagen 7 compositions23 Jul 2026US 2026/0209315 A1Phoenix Tissue Repair, Inc.
- Biocatalysts and methods for hydroxylation of chemical compounds18 Sep 2025US 2025/0290049 A1Codexis, Inc.
- Butyrate Analogues and Methods of Use for HIF Stabilization and Treatment of Bowel Disease24 Jul 2025US 2025/0235418 A1The Regents of the University of Colorado, a body corporate
- Recombinant Spider Silk-Reinforced Collagen Proteins Produced in Plants and the Use Thereof24 Jul 2025US 2025/0236651 A1
Most cited
By later US patents
- Synthesis of human procollagens and collagens in recombinant DNA systems34US 5,593,859 AThomas Jefferson University · 1997
- Pharmaceuticals and methods for treating hypoxia and screening methods therefor24US 6,855,510 B2Dana-Farber Cancer Institute, Inc. · 2005
- Naphthyridine derivatives as inhibitors of hypoxia inducible factor (HIF) hydroxylase15US 8,921,389 B2FibroGen, Inc. · 2014
- Process for producing trans-4-hydroxy-L-proline12US 5,854,040 AKyowa Hakko Kogyo Co., Ltd. · 1998
- Synthesis of human procollagens and collagens in recombinant DNA systems11US 5,405,757 AThomas Jefferson University · 1995